$6.57
0.7112.12%
Last update: Oct 30, 4:34 PM
Profound Medical Corp
PROFNASDAQ
Profound Medical (PROF) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Profound Medical (PROF) last issued guidance on October 7, 2026 for Q3 2026. The company guided revenue in the range of $9.8M - $10M for the period.
Compared to prior guidance, Profound Medical lowered its revenue forecast from a prior range of $25M - $25M.
Profound Medical has issued 10 guidance updates between January 3, 2024 and October 7, 2026. During this period, the company raised its outlook 4 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.24 | $-0.25 | $-0.27 | $-0.38 |
| Actual | $-0.26 | $-0.19 | $-0.27 | $-0.26 |
| Surprise | -8.33% | +24.0% | 0.00% | +31.6% |
| Revenue | ||||
| Estimate | $6.3M | $6.3M | $9.4M | $7.1M |
| Actual | $2.5M | $5.3M | $6.0M | $5.3M |
| Surprise | -60.8% | -15.8% | -36.3% | -25.3% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.19 | $-0.19 | $-0.20 | $-0.19 |
| Revenue | ||||
| Consensus | $13.1M | $12.1M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.26 | $-0.24 | -8.33 % |
| Q1 | May 7, 2026 | $-0.19 | $-0.25 | 24.0 % |
| Q4 | Mar 5, 2026 | $-0.27 | $-0.27 | 0.00 % |
| Q3 | Nov 13, 2025 | $-0.26 | $-0.38 | 31.6 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $2.48M | $6.34M | -60.8 % |
| Q1 | May 7, 2026 | $5.34M | $6.34M | -15.8 % |
| Q4 | Mar 5, 2026 | $5.98M | $9.38M | -36.3 % |
| Q3 | Nov 13, 2025 | $5.29M | $7.08M | -25.3 % |
